Imbricatin is primarily investigated for its potential anti-inflammatory and neuroprotective properties. It has shown promise in preclinical studies for modulating pathways involved in oxidative stress and neuronal damage, making it a candidate of interest in research related to neurodegenerative conditions such as Alzheimer's and Parkinson's diseases. Additionally, imbricatin exhibits antimicrobial activity against certain pathogens, suggesting possible use in developing new antimicrobial agents. Its ability to interact with cellular signaling pathways also supports ongoing exploration in cancer research, particularly in understanding tumor cell proliferation and apoptosis. Most applications remain in the experimental stage, with studies conducted in vitro or in animal models.